Advanced search
1 file | 252.69 KB Add to list

Rituximab synergizes with hydroxyurea or vincristine in the killing of Ramos Burkitt's lymphoma B cell line

Author
Organization
Keywords
COMBINATION, DRUGS, APOPTOSIS, CYCLE, CHOP CHEMOTHERAPY, MONOCLONAL-ANTIBODY, NON-HODGKINS-LYMPHOMA

Downloads

  • 2263 14Deyab.pdf
    • full text
    • |
    • open access
    • |
    • PDF
    • |
    • 252.69 KB

Citation

Please use this url to cite or link to this publication:

MLA
Deyab, Mohamed, Abdulrhman Elbanani, Salah Tabal, et al. “Rituximab Synergizes with Hydroxyurea or Vincristine in the Killing of Ramos Burkitt’s Lymphoma B Cell Line.” CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS 29.2 (2014): 87–90. Print.
APA
Deyab, M., Elbanani, A., Tabal, S., Geriani, H., Lamami, Y., Bredan, A., & Abulayha, A. (2014). Rituximab synergizes with hydroxyurea or vincristine in the killing of Ramos Burkitt’s lymphoma B cell line. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 29(2), 87–90.
Chicago author-date
Deyab, Mohamed, Abdulrhman Elbanani, Salah Tabal, Hajer Geriani, Yosra Lamami, Amin Bredan, and Abdulmunem Abulayha. 2014. “Rituximab Synergizes with Hydroxyurea or Vincristine in the Killing of Ramos Burkitt’s Lymphoma B Cell Line.” Cancer Biotherapy and Radiopharmaceuticals 29 (2): 87–90.
Chicago author-date (all authors)
Deyab, Mohamed, Abdulrhman Elbanani, Salah Tabal, Hajer Geriani, Yosra Lamami, Amin Bredan, and Abdulmunem Abulayha. 2014. “Rituximab Synergizes with Hydroxyurea or Vincristine in the Killing of Ramos Burkitt’s Lymphoma B Cell Line.” Cancer Biotherapy and Radiopharmaceuticals 29 (2): 87–90.
Vancouver
1.
Deyab M, Elbanani A, Tabal S, Geriani H, Lamami Y, Bredan A, et al. Rituximab synergizes with hydroxyurea or vincristine in the killing of Ramos Burkitt’s lymphoma B cell line. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS. 2014;29(2):87–90.
IEEE
[1]
M. Deyab et al., “Rituximab synergizes with hydroxyurea or vincristine in the killing of Ramos Burkitt’s lymphoma B cell line,” CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, vol. 29, no. 2, pp. 87–90, 2014.
@article{4349516,
  author       = {Deyab, Mohamed and Elbanani, Abdulrhman and Tabal, Salah and Geriani, Hajer and Lamami, Yosra and Bredan, Amin and Abulayha, Abdulmunem},
  issn         = {1084-9785},
  journal      = {CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS},
  keywords     = {COMBINATION,DRUGS,APOPTOSIS,CYCLE,CHOP CHEMOTHERAPY,MONOCLONAL-ANTIBODY,NON-HODGKINS-LYMPHOMA},
  language     = {eng},
  number       = {2},
  pages        = {87--90},
  title        = {Rituximab synergizes with hydroxyurea or vincristine in the killing of Ramos Burkitt's lymphoma B cell line},
  url          = {http://dx.doi.org/10.1089/cbr.2013.1557},
  volume       = {29},
  year         = {2014},
}

Altmetric
View in Altmetric
Web of Science
Times cited: